Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Zorn

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Purinergic Signalling|August 24, 2022
Inhibition of P2X7 receptors by Lu AF27139 diminishes colonic hypersensitivity and CNS prostanoid levels in a rat model of visceral painRoland G W Staal, Adarsh Gandhi, Hua Zhou, et al.
Journal of Medicinal Chemistry|January 5, 1996
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agentsH R Howard, J A Lowe, T F Seeger, et al.
European Journal of Pain (London, England)|April 7, 2022
P2X7 receptor-mediated release of microglial prostanoids and miRNAs correlates with reversal of neuropathic hypersensitivity in ratsRoland Staal, Tanzilya Khayrullina, Rie Christensen, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonistM A Sanner, T A Chappie, A R Dunaiskis, et al.
Journal of Medicinal Chemistry|April 6, 2021
Synthesis and Characterization of the Novel Rodent-Active and CNS-Penetrant P2X7 Receptor Antagonist Lu AF27139Allen T Hopper, Martin Juhl, Jorrit Hornberg, et al.
Nature Immunology|October 17, 2018
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegenerationJae Kyu Ryu, Victoria A Rafalski, Anke Meyer-Franke, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Purinergic Signalling|August 24, 2022
Inhibition of P2X7 receptors by Lu AF27139 diminishes colonic hypersensitivity and CNS prostanoid levels in a rat model of visceral painRoland G W Staal, Adarsh Gandhi, Hua Zhou, et al.
Journal of Medicinal Chemistry|January 5, 1996
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agentsH R Howard, J A Lowe, T F Seeger, et al.
European Journal of Pain (London, England)|April 7, 2022
P2X7 receptor-mediated release of microglial prostanoids and miRNAs correlates with reversal of neuropathic hypersensitivity in ratsRoland Staal, Tanzilya Khayrullina, Rie Christensen, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonistM A Sanner, T A Chappie, A R Dunaiskis, et al.
Journal of Medicinal Chemistry|April 6, 2021
Synthesis and Characterization of the Novel Rodent-Active and CNS-Penetrant P2X7 Receptor Antagonist Lu AF27139Allen T Hopper, Martin Juhl, Jorrit Hornberg, et al.
Nature Immunology|October 17, 2018
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegenerationJae Kyu Ryu, Victoria A Rafalski, Anke Meyer-Franke, et al.
Pageof 9